Given that the prognosis of the mesenchymal and classical GBM subtype are considered to be worse than that of other subtypes32, 33, STAT3 mRNA expression in the mesenchymal and classical GBM subtypes was higher than that in the neural and proneural GBM subtypes (Figure 1E-G). The gene discussed is STAT3; the disease is glioblastoma.